Annual Shareholders Equity
$34.21 M
-$12.70 M-27.08%
31 December 2023
Summary:
Purple Biotech annual stockholders equity is currently $34.21 million, with the most recent change of -$12.70 million (-27.08%) on 31 December 2023. During the last 3 years, it has fallen by -$30.62 million (-47.23%). PPBT annual shareholders equity is now -92.64% below its all-time high of $464.75 million, reached on 01 December 2009.PPBT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$29.41 M
+$95.00 K+0.32%
01 September 2024
Summary:
Purple Biotech quarterly stockholders equity is currently $29.41 million, with the most recent change of +$95.00 thousand (+0.32%) on 01 September 2024. Over the past year, it has dropped by -$4.80 million (-14.02%). PPBT quarterly shareholders equity is now -62.95% below its all-time high of $79.39 million, reached on 31 December 2020.PPBT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PPBT Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -14.0% |
| 3 y3 years | -47.2% | -54.6% |
| 5 y5 years | +228.3% | +182.2% |
PPBT Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -47.2% | at low | -54.6% | +0.3% |
| 5 y | 5 years | -56.9% | +228.3% | -63.0% | +182.2% |
| alltime | all time | -92.6% | +3716.0% | -63.0% | >+9999.0% |
Purple Biotech Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $29.41 M(+0.3%) |
| June 2024 | - | $29.32 M(-5.5%) |
| Mar 2024 | - | $31.02 M(-9.3%) |
| Dec 2023 | $34.21 M(-27.1%) | $34.21 M(-11.4%) |
| Sept 2023 | - | $38.60 M(-9.4%) |
| June 2023 | - | $42.60 M(-9.1%) |
| Mar 2023 | - | $46.88 M(-0.1%) |
| Dec 2022 | $46.91 M(-27.6%) | $46.91 M(-9.6%) |
| Sept 2022 | - | $51.89 M(-6.4%) |
| June 2022 | - | $55.41 M(-4.6%) |
| Mar 2022 | - | $58.06 M(-10.4%) |
| Dec 2021 | $64.83 M(-18.3%) | $64.83 M(-6.1%) |
| Sept 2021 | - | $69.06 M(-3.8%) |
| June 2021 | - | $71.80 M(-4.0%) |
| Mar 2021 | - | $74.75 M(-5.8%) |
| Dec 2020 | $79.39 M(+661.8%) | $79.39 M(+42.4%) |
| June 2020 | - | $55.74 M(+434.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $10.42 M(-1.0%) | $10.42 M(-5.2%) |
| June 2019 | - | $10.99 M(+4.4%) |
| Dec 2018 | $10.52 M(+42.0%) | $10.52 M(+3.8%) |
| June 2018 | - | $10.14 M(+36.9%) |
| Dec 2017 | $7.41 M(-44.7%) | $7.41 M(-30.4%) |
| June 2017 | - | $10.64 M(-20.5%) |
| Dec 2016 | $13.38 M(+42.0%) | $13.38 M(+89.3%) |
| June 2016 | - | $7.07 M(-25.0%) |
| Dec 2015 | $9.43 M(+1119.8%) | $9.43 M(+7097.7%) |
| Sept 2015 | - | $131.00 K(-88.4%) |
| June 2015 | - | $1.13 M(+46.4%) |
| Dec 2014 | $773.00 K(-181.7%) | $773.00 K |
| Dec 2013 | -$946.00 K(-100.3%) | - |
| Dec 2012 | $371.75 M(-7.6%) | - |
| Dec 2011 | $402.19 M(-6.4%) | - |
| Dec 2010 | $429.84 M(-7.5%) | - |
| Dec 2009 | $464.75 M | - |
FAQ
- What is Purple Biotech annual stockholders equity?
- What is the all time high annual shareholders equity for Purple Biotech?
- What is Purple Biotech quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Purple Biotech?
- What is Purple Biotech quarterly shareholders equity year-on-year change?
What is Purple Biotech annual stockholders equity?
The current annual shareholders equity of PPBT is $34.21 M
What is the all time high annual shareholders equity for Purple Biotech?
Purple Biotech all-time high annual stockholders equity is $464.75 M
What is Purple Biotech quarterly stockholders equity?
The current quarterly shareholders equity of PPBT is $29.41 M
What is the all time high quarterly shareholders equity for Purple Biotech?
Purple Biotech all-time high quarterly stockholders equity is $79.39 M
What is Purple Biotech quarterly shareholders equity year-on-year change?
Over the past year, PPBT quarterly stockholders equity has changed by -$4.80 M (-14.02%)